Jump Financial, LLC Roivant Sciences Ltd. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$9.76 - $13.19 $4.07 Million - $5.5 Million	416,667 New	416,667 $4.87 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $558,445 - $1.33 Million	166,204 New	166,204 $1.33 Million
Q2 2022 Aug 09, 2022	SELL	$2.81 - $4.84 $115,892 - $199,616	-41,243 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.74 - $9.91 $195,491 - $408,718	41,243 New	41,243 $203,000

308

496M

989K

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.49B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.